Working… Menu
Trial record 1 of 1 for:    MonDAFIS | Stroke
Previous Study | Return to List | Next Study

Impact of Standardized MONitoring for Detection of Atrial Fibrillation in Ischemic Stroke (MonDAFIS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02204267
Recruitment Status : Completed
First Posted : July 30, 2014
Last Update Posted : November 13, 2020
Bayer Healthcare Pharmaceuticals, Inc./Bayer Schering Pharma
Information provided by (Responsible Party):
Matthias Endres, Charite University, Berlin, Germany